Asbestos as a possible major cause of malignant lung tumors (including small cell carcinoma, Adenocarcinoma & Mesothelioma), brain tumors (i.e. astrocytoma & glioblastoma multiforme), many other malignant tumors, intractable pain including fibromyalgia, & some cardio-vascular pathology: Safe & effective methods of reducing asbestos from normal & pathological areas

Acupuncture and Electro-Therapeutics Research

Volumn 31, Issue 1-2, 2006, Pages 61-125

  Omura, Yoshiaki ^a,b,c,d,e,f  

^a Heart Disease Research Foundation   (United States)

^b Int'l College of Acupuncture and Electro Therapeutics   (United States)

^c Japan Bi Digital O Ring Test Medical Society   (Japan)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^f NONE   (United States)

Author keywords

Acupuncture; Asbestos; Astrocytoma; Cardio Vascular Diseases Fibromyalgia; DHEA; Glioblastoma Multiforme; Intractable Itchiness; Intractable Pain; Malignant Tumors (Lung, Brain, Breast, Ovary, Esophagus, Colon); Mesothelioma; Telomere

Indexed keywords

ARSENIC; ASBESTOS; CHROMIUM; PRASTERONE; SELENIUM; THROMBOXANE B2; ZINC;

ALOPECIA; ALZHEIMER DISEASE; ASBESTOSIS; ASTROCYTOMA; AUTISM; BRAIN TUMOR; BREAST ADENOCARCINOMA; CANCER CELL; CARDIOVASCULAR DISEASE; CATARACT; CORIANDER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FIBROMYALGIA; GLIOBLASTOMA; HEART FAILURE; HEART INFARCTION; HOT FLUSH; HUMAN; INTRACTABLE PAIN; LARYNX CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MESOTHELIOMA; MYELOID LEUKEMIA; REVIEW; TELOMERE; VARICOSIS;

EID: 33749423087     PISSN: 03601293     EISSN: None     Source Type: Journal    
DOI: 10.3727/036012906815844300     Document Type: Review

References (56)

1. Pass, H.I., Lott, D., Lonardo, F., Harbut, M., Liu, Z., Tang, N., Carbone, M., Webb, C., Wali, A. "Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin." New England Journal of Medicine, 353:1564-1573, 2005.
2. Fujiwara, H., Kamimori, T., Morinaga, K., Takeda, Y., Kohyama, N., Miki, Y., Inai, K., Yamamoto, S. "An Autopsy Case of Primary Pericardial Mesothelioma In Arc Cutter Exposed to Asbestos Through Talc Pencils." Industrial Health, 43(2):346-50, 2005.
3. Henderson, D.W., Rodelsperger, K., Woitowitz, H.J., Leigh, J. "After Helsinki: A Multidisciplinary Review of the Relationship Between Asbestos Exposure and Lung Cancer, With Emphasis on Studies Published During 1997-2004." Pathology, 36(6):517-550, 2004.
4. Reid, A., de Klerk, N., Ambrosini, G.L., Olsen, N., Pang, S.C., Berry, G., Musk, A.W. "The Effect of Asbestosis On Lung Cancer Risk Beyond the Dose Related Effect of Asbestos Alone." Occupational Environmental Medicine, 62(12):885-889, 2005.
5. Liu, Y., Zhang, P., Yi, F. "Asbestos Fiber Burdens In Lung Tissues of Hong Kong Chinese With and Without Lung Cancer." Lung Cancer, 32(2):113-116, 2001.
6. Reid, A. Ambrosini, G., de Klerk, N., Fritschi, L, Musk, B. "Aerodigestive and Gastrointestinal Tract Cancers and Exposure to Crocidolite (blue asbestos): Incidence and Mortality Among Former Crocidolite Workers." International Journal of Cancer, 111(5):757-761, 2004.
7. Marinaccio, A., Montanaro, F., Mastrantonio, M., Uccelli, R., Altavista, P., Nesti, M., Costantini, A.S., Gorini, G. "Predictions of Mortality From Pleural Mesothelioma In Italy: a Model Based On Asbestos Consumption Figures Supports Results From Age-Period-Cohort Models." International Journal of Cancer, 115(1):142-147, 2005.
8. de La Provote, S., Desoubeaux, N., Paris, C., Letourneux, M., Raffaelli, C., Galateau-Salle, F., Gignoux, M., Launoy, G. "Incidence of Digestive Cancers and Occupational Exposure to Asbestos." European Journal of Cancer Prevention, 11(6):523-528, 2002.
9. Mollo, F., Magnani, C., Bo, P., Burlo, P., Cravello, M. "The Attribution of Lung Cancers to Asbestos Exposure." American Journal of Clinical Pathology, 117(1):90-95, 2002.
10. Aliyu, O., Cullen, M., Barnett, M., Balmes, J., Cartmel, B., Redlich, C., Brodkin, C., et al. "Evidence For Excess Colorectal Cancer Incidence Among Asbestos-Exposed Men In the Beta-Carotene and Retinol Efficiency Trial." American Journal of Epidemiology, 162:868-878, 2005.
11. McNaughton, W.M., Broughton, M.E., Toner, G.C., Schwarz, M.A. "Presentation of Malignant Pleural Mesothelioma With Cerebral Metastases." Journal of the Royal Society of Medicine, 83:466-467, July 1990.
12. LaDou, J. "The Asbestos Cancer Epidemic." Environmental Health Perspectives, 112(3): 285-290, March 2004.
13. Yoshino, I., Yamaguchi, M., Okamoto, T., Ushijima, C., Fukuyama, Y., Ichinose, Y., Maehara, O. "Multmodal Treatment for Resesctable Epithelial Type Malignant Pleural Mesothelioma." World Journal of Surgical Oncology, 2:11, May 5, 2004.
14. Environmental Protection Agency, "Asbestos Materials Bans: Clarification, May 18, 1999", May 1999. June 21, 2006 〈http://www.epa. gov/asbestos/pubs/ashbans2.pdf〉
15. Chatfield, E.J., M.J. Dillon. "Analytical Method for the Determination of Asbestos in Water." Environmental Protection Agency No. 600/4-83-043.
16. Burdett, G.J., A.P. Rood, "Membrane-Filter Direct-Transfer Technique for the Analysis of Asbestos Fibers or Other Inorganic Particles by Transmission Electron Microscopy." Evirononmental Science & Technology. Vol. 17 pp. 643-648, 1983.
17. Chopra, K.S. "Interlaboratory Measurements of Amphibole and Chrysotile Fiber Concentrations in Water." National Bureau of Standards Special Publication 506, Proceedings of the Workshop on Asbestos: Definitions and Measurement Methods, 1977.
18. USEPA, "Asbestos-Containing Materials in Schools: Final Rule and Notice." Federal Register, 40 CFR Part 763. Appendix A to Subpart E., October 30, 1987.
19. Brackett, K.A., Clark, P.J., Millette, J.R. "Method 100.2: Determination of Asbestos Structures Over 10 μm in Length of Drinking Water." Office of Research And Development U.S. Environmental Protection Agency, pp. 1-22. Cincinatti, Ohio: June 1994.
20. Martinez, E. "Sad Farewell to Hero EMS Ma: Kin hail 9/11 medic who died of cancer." New York Post. p 17, March 21, 2006
21. DePalma, A. "Tracing Lung Ailments That Rose With 9/11 Dust: Tracing Lung Ailments That Rose With the Dust of Ground Zero." The New York Times. pp. A1 & B5, May 13, 2006.
22. Public Citizen's Congress Watch. "Federal Asbestos Legislation: The Winners Are..." Public Citizen. Washington D.C., pp. 1-44, May 2005.
23. Robson, B. "Public Health Facts: Asbestos." Winnipeg Free Press, Canada, pp. 1-3, February 1987.
24. Omura, Y. "Simple non-invasive early detection and localization of specific cancer tissues of internal organs and differentiation of cancer tissue from surrounding areas infected by cancer related viruses, as well as evaluation of their micro-circulatory condition & drug uptake using the Bi-Digital O-Ring Test." Acupuncture & Electro-Therapeutics Research, The International Journal., Vol 15: No. 3 & 4, pp. 217-233, 1990.
25. Omura, Y., Losco, Bro. M., Omura, A.K., Yamamoto, S., Ishikawa, H., Takeshige, C., Watari, N., Nakajima, H., Matsubara, T. "Bi-Directional transmission of molecular information by photons or electron beams passing in the close vicinity of specific molecules, and its clinical and basic research applications: 1) Diagnosis of humans or animal patients without any direct contact; 2) light microscopic and electron microscopic localization of neuro-transmitters, heavy metals, oncogen C-fos (AB2), etc. of intracellular fine structures of normal and abnormal single cells using light or electron-microscopic indirect Bi-Digital O-Ring Test." Acupuncture & Electro-Therapeutics Research, The International Journal, Vol 17: No. 1, pp. 29-46, 1992.
26. Omura, Y. "Transmission of molecular information through electro-magnetic waves with different frequencies and its application to non-invasive diagnosis of patients as well as detection from patient's x-ray film of visible and not visible medical information: part 1." Acupuncture & Electro-Therapeutics Research. The International Journal., Vol. 19, No. 1, pp. 39-63, 1994.
27. Omura, Y., Ishida, Y. "Search for the Mechanism of Bio-Sensor: When Given Medication is Ineffective what do You Suspect? How do you Identify Whether Drug is Reaching the Pathological Area to be Treated? How do You Judge the Drug-Drug Interaction? Listen to the Originator of the Bi-Digital O-Ring Test, Yoshiaki Omura." Sawarabi.(Japanese Quarterly Medical Journal Published by Medical Review Publishing Co., Osaka, Japan) No. 18, pp. 30-36, April 1, 1994.
28. Omura, Y., Lorberboym, M., Beckman, S. "Radiation Injury & Mercury Deposits in internal Organs as a Result of Thallium-201 Intravenous Injection for SPECT Imaging; Additional Biochemical Information Obtained in the Images of Organs from SPECT or PET Scans; and Potential Injury Due to Radiation Exposure During Long-Distance Flights." Acupuncture & Electro-Therapeutics Research. The International Journal, Vol. 20, No. 2, pp. 133-148, 1995.
29. Omura, Y., Beckman, S. "Role of Mercury (Hg) in Resistant Infections & Effective Treatment of Chlamydia Trachomatis and Herpes Family Viral Infections (and Potential Treatment for Cancer) by Removing Localized Hg Deposits with Chinese Parsley and Delivering Effective Antibiotics Using Various Drug Uptake Enhancement Methods." Acupuncture & Electro-Therapeutics research. The International Journal, Vol. 20, Nos. 3 & 4, pp. 195-229, 1995.
30. Omura, Y., Shimotsuura, Y., Fukuoka, A., Nomoto, T. "Significant Mercury Deposits in Internal Organs Following the Removal of Dental Amalgam, & Development of Pre-Cancer on the Gingiva and the Sides of the Tongue and Their Represented Organs as a Result of Inadvertent Exposure to Strong Curing Light (Used to Solidify Synthetic Dental Filling Material) & Effective Treatment: A Clinical Case Report, along with Organ Representation Areas for Each Tooth." Acupuncture & Electro-Therapeutics research, The International Journal, Vol. 21, No.2. pp. 133-160, 1996.
31. Omura, Y. "Medical and Dental Problems Associated with Amalgam and the Hazards of Strong Ultraviolet Radiation used to Solidify Other Synthetic Materials as Replacements for Amalgam, and Imaging of the 4 Components of TMJ & Invisible, Hidden Pathological Findings in X-Ray Images, CT Scans, & MRI Films, and Ultrasonic Images, Detected by the Bi-Digital O-Ring Test for Diagnosis and Treatment of Difficult Dental & Medical Problems." 6th Congress of the Japan Bi-Digital O-Ring Test Medical Society, pp. 50-51, Tokyo University, Tokyo, Japan, 1996 Aug 8-10.
32. Omura, Y. "Early Non-Invasive Cancer Screening by Detecting Levels of Integrin α5β1, Oncogene C-fos Ab-2, Hg, Acetylcholine, Viral Infection, NO, D-Glucose, p53 (Ab-5) & Rb (Ab-8), and a New Safe and Effective Cancer Therapy Using a Mixture of EPA & DHA as an Anti-Viral Agent, & Cilantro to Remove Intracellular Mercury and "Selective Drug Uptake Enhancement Method" Based on the Bi-Digital O-Ring Test Evaluation." 8th Cngress of the Japan Bi-Digital O-Ring Test Medical Society, pp. 58-59, Showa University, Tokyo, Japan, 1998 Jul 19-20.
33. Omura, Y. "Electromagnetic Field Hypersensitivity, Cancer, Pre-Cancer & Abnormal Pure (-) Qi Gong Energy Emission." Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 23, No. 3 & 4, pp. 225-226, 1998.
34. Omura, Y. "Inter-relationship Among "Electromagnetic Field Hypersensitivity Syndrome", "(-) Qi Syndrome", Pre-Cancer and Cancer: New Methods of Reversing Abnormal (-) Qi to Normal (+) Qi Energy." Presented at 14th International Symposium on Acupuncture & Electro-Therapeutics Held at Columbia University during October 22-25, 1998, Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 23, No. 3 & 4, pp. 259-260, 1998.
35. Omura, Y. "Application of the Bi-Digital O-Ring Test for the Localization of Accurate Organ Representation Areas at Different Parts of the Body, their Clinical Application for Diagnosis and Treatment, & their Comparison with Traditional Chinese & Ayurvedic Representation Areas, and the Effect of Acupuncture on Homocysteine, Cardiac Troponin I, and Telomere in Normal and Cancer Cells." Abstract of the 1st Spanish Inter-university Congress on Acupuncture (I Congreso Interuniversitario Espanol De Acupunctura). organized by 5 medical schools and the Spanish Government, published by the Faculty of Medicine, University of Zaragoza, Spain, pgs.89-91, Sept. 30-Oct. 3, 1999.
36. Omura, Y. "The Application of (+) Qi Gong stored energy for the treatment of various intractable medical problems, including pain, neuromuscular problems, undesirable (-) Qi dominant state, and Electromagnetic Field Hypersensitivity (which is a frequent cause of depression, stroke, pre-Alzheimer's disease, autism and cancer)." Abstract published in QiGong Summit 2000 by the American Qigong Association and The East West Academy of Healing Arts, April 21-23, 2000, pgs. 17-18.
37. Omura, Y. "Abnormal Deposits of Al, Pb, and Hg in the Brain, Particularly in the Hippocampus, as One of the Main Causes of Decreased Cerebral Acetylcholine, Electromagnetic Hypersensitivity, Pre-Alzheimer's Disease, and Autism in Children and Their New Effective Treatment by the Selective Drug Uptake Enhancement Method (Part I)." Abstract published in Program & Abstracts of the 4th International Symposium on The Bi-Digital O-Ring Test held at Ibuka Auditorium, Wasada University in Tokyo, Japan, July 21-23, 2000, pgs. 126-127; updated article reprinted in Acupuncture & Electro-Therapeutics Research. The International Journal, Vol. 25, No. 3-4, pgs. 230-232, 2000.
38. Omura, Y. "Abnormal Deposits of Al, Pb, and Hg in the Brain, Particularly in the Hippocampus, as one of the Main Causes of Decreased Cerebral Acetylcholine, Electromagnetic Field Hypersensitivity, Pre-Alzheimer's Disease, and Autism in Children and Their New effective Treatment by Removing These Metal Deposits Using Cilantro and the Selective Drug Uptake Enhancement Method (Part I)." presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 26, No. 1-2, pgs. 102-104, 2001.
39. Omura, Y. "Non-Invasive 6-Minute Screening of Pre-Alzheimer's Disease By Estimating Amounts of Acetylcholine, β-Amyloid (1-42), Al, Hg & Pb of the Brain, and the Safe & Effective Treatment of Pre-Alzheimer's Disease Using the 'Selective Drug Uptake Enhancement Method'." pgs. 75-76, Abstract of 5th Biennial International Symposium on Bi-Digital O-Ring Test, organized and published by Japan Bi-Digital O-Ring Test Medical Society, held at Ibuka International Auditorium, Waseda University, Tokyo, Japan, during July 19-21, 2002, reprinted in Acupuncture & Electro-Therapeutics Research, The International Journal Vol. 27, 3&4,pgs.226-227, 2002.
40. Omura, Y. "Quick and Non-Invasive Screening & Diagnosis of Cancer by Measuring Telomere, 8-OH-dG, Integrin a5β1, Acetylcholine, Hg etc. and Safe & Effective Treatment of Cancer: Marked Decrease of the Telomere of Cancer Cell & Increase of the Normal Cell Telomere by Stimulating the Press Needle Inserted at True St. 36 and Effective Treatment & Longevity Effect of Selective Drug Uptake Enhancement Method." Program & Abstracts of 6th Biennial International Symposium on the Bi-Digital O-Ring Test, Pgs 84-88, held at Waseda University, Tokyo, Japan, August 6-8, 2004 (Summary of 45 minute presentation as the main guest speaker.)
41. Omura, Y. "Non-Invasive Quick Screening of Cancer, Cardio-Vascular Disease, Alzheimer's Disease and Cause of Intractable pain and Their Accurate Localization Using X-, Y-Axis Laser Line Scanning of the Whole Body & New, Safe and Effective Treatments with the Selective Drug Uptake Enhancement Method." in book Science of Whole Person Healing: Proceedings of the First Interdisciplinary International Conference, Volume 2, edited by Rustum Roy, pgs 47-96 of 418 pg book published in 2004 by iUniverse, Inc., New York, Lincoln, Shanghai. Original meeting was held in Bethesda, MD, March 28-30, 2003.
42. Omura, Y. "Non-Invasive Diagnosis & Effective Treatment of Chronic Intractable Lower Back Pain Using the Bi-Digital O-Ring Test Resonance Phenomenon & The Selective Drug Uptake Enhancement Method." pp. 65-74, in the hardcover book Management of Pain: A World Perspective, ed. H. Yanagida, K. Hanaoka & O. Yuge, published as part of the 9th International Symposium on Pain, organized by the International Association for the Study of Pain, by Monduzzi Editore, Bologna, Italy, 2000.
43. Omura, Y. "Major Causes of Electromagnetic Field Hypersensitivity, Strong (-) Qi, Pre-Alzheimer's & Alzheimer's Disease, Autism & Abnormal Mental or Motor Function, & Cancer; Their Effective Treatment Using The Selective Drug Uptake Enhancement Method with (+) Qi Gong Energy-Stored paper, and Normal Cell Telomere-Increasing Effect & Cancer Cell Telomere-Decreasing Effect of (+) Qi Gong Energy-Stored Paper on True St. 36", Summary of one hour lecture presented at the International Symposium on Bridging Worlds and Filling Gaps in the Science of Healing, held November 29-December 3, 2001 at Kona, organized by Dr. Wayne Jonas of the Samueli Institute, who is the former Director of the Alternative Medicine section of N.I.H., Dr. Marilyn Schlitz of Noetic Sciences and Dr.Mitchell W. Krucoff of Duke University. Published in the 482 page book Proceedings: Bridging Worlds and Filling Gaps in the Science of Healing (Edited by Ronald A. Chez), Noetic Science, pgs. 150-176, April, 2002.
44. Omura, Y. "Beneficial Effects & Side Effects of DHEA: True Anti-Aging & Age-Promoting Effects, as well as Anti-Cancer & Cancer-Promoting Effects of DHEA Evaluated from the Effects on the Normal & Cancer Cell Telomeres & Other Parameters." Acupuncture & Electro-Therapeutics Research. International Journal, Vol. 30, Nos. 3&4, pp. 219-261, 2005.
45. Omura, Y. "Special Sunrise & Sunset Solar Energy Stored Papers and Their Clinical Applications for Intractable Pain, Circulatory Disturbances & Cancer: Comparison of Beneficial Effects Between Special Solar Energy Stored Paper and Qigong Energy Stored Paper." Acupuncture & Electro-Therepeutics Research, The International Journal, Volume 29, Number 1/2, pgs. 1-42, 2004.
46. Raloff, J. "Dirty Little Secret: Asbestos Laces Many Residential Soils." Science News, Volume 17, Number 2, pp. 26-28, July 8, 2006.
47. OM Group, "Fuel Oil Additives", July 8, 2006, 〈http://www.omgi.com/buprod/metal_organics/productshomogeneous_catalysts/ default.asp〉
48. Agency for Toxic Substances and Disease Registry (ATSDR). "Toxicological Profile for Chromium." U.S. Public Health Service, U.S. Department of Health and Human Services, Atlanta, GA, 1998.
49. U.S. Environmental Protection Agency, "Toxicological Review of Trivalent Chromium." National Center for Environmental Assessment, Office of Research and Development, Washington, D.C., 1998.
50. U.S. Environmental Protection Agency, "Toxicological Review of Hexavalent Chromium." National Center for Environmental Assessment, Office of Research and Development, Washington, D.C., 1998.
51. World Health Organization. Chromium. "Environmental Health Criteria 61." Geneva, Switzerland, 1988.
52. U.S. Environmental Protection Agency, "Integrated Risk Information System (IRIS) on Chromium VI." National Center for Environmental Assessment, Office of Research and Development, Washington, D.C., 1999.
53. Occupational Safety and Health Administration (OSHA). "Code of Federal Regulations." Occupational Safety and Health Standards, Toxic and Hazardous Substances. 29 CFR 1910.1000, 1998.
54. National Institute for Occupational Safety and Health (NIOSH). "Pocket Guide to Chemical Hazards." U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. Cincinnati, OH, 1997.
55. Environmental Protection Agency, "Chromium Compounds: Hazard Summary-Created in April 1992; Revised in January 2000", January 2000. June 21, 2006 〈http://www.epa.gov/rtn/atw/hlthef/chromium.htm〉
56. Proctor DM, Otani JM, Finley BL, Paustenbach DJ, Bland JA, Speizer N, Sargent EV. "Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review." Journal of Toxicology & Environmental Health, Vol 65(10): p. 701-746, 2002.